Genomics of lung cancer may change diagnosis, prognosis and therapy
- 1 March 2005
- journal article
- review article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 11 (1) , 5-10
- https://doi.org/10.1007/bf03032399
Abstract
Despite significant improvements in tumor management in general, the prognosis of lung cancer patients remains dismal. It is a hope that our increasing knowledge in molecular aspects of tumor development, growth and progression will open new targets for therapeutic interventions. In this review we discuss some of the more recent results of this field. This includes the susceptibility factors, an association between genetic changes in EGFR pathway and tyrosine kinase inhibitors, the role of gene hypermethylation and genetic profiling, as well as different molecular aspects of tumor progression. Available data all support that lung cancer is a group of diseases with not only distinct histological but with similarly different genetic characters. Accordingly, the diagnosis, prognosis and therapy must accommodate this heterogeneity.Keywords
This publication has 51 references indexed in Scilit:
- Growth Factor Independence-1 Is Expressed in Primary Human Neuroendocrine Lung Carcinomas and Mediates the Differentiation of Murine Pulmonary Neuroendocrine CellsCancer Research, 2004
- Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lungLung Cancer, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancerInternational Journal of Cancer, 2004
- Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLCEuropean Journal of Cardio-Thoracic Surgery, 2004
- COX-2, MMP-9, and Noguchi Classification Provide Additional Prognostic Information About Adenocarcinoma of the LungAmerican Journal of Clinical Pathology, 2004
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002